Evidence map›Paper›PMID 41601313›Full record

ArticleDevelopment (Cambridge, England)2026

The RNA-binding protein SRSF3 controls epicardial formation by regulating splicing and proliferation.

Irina-Elena Lupu, Susann Bruche, Anob M Chakrabarti, Ian R McCracken, Quang M Dang, Tamara Carsana, Sarah De Val, Andia N Redpath, Nicola Smart

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Nuclear m6A Methylase METTL3 Drives Production of ITGβ4E to Exacerbate Heart Failure via SRSF3-Mediated Alternative Splicing of ITGβ4.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Irina-Elena LupuInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0002-0869-8525
Susann BrucheInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0002-5814-7166
Anob M ChakrabartiRNA Virus Replication Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.ORCID 0000-0002-6841-5718
Ian R McCrackenInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0001-8806-548X
Quang M DangInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0009-0000-7083-8560
Tamara CarsanaInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0009-0004-3387-3171
Sarah De ValInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0002-2566-2348
Andia N RedpathInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0002-3620-4983
Nicola SmartInstitute of Developmental and Regenerative Medicine, British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX3 7TY, UK.ORCID 0000-0002-3501-7254

Funding

British Heart Foundation FS/13/4/30045British Heart Foundation FS/15/68/32042British Heart Foundation FS/19/32/34376British Heart Foundation PG/15/112/31940British Heart Foundation PG/24/11910British Heart Foundation RM/13/3/30159British Heart Foundation Centre of Regenerative Medicine RM/13/3/30159University of Oxford
6 · The paper itself

Abstract

The epicardium is a fundamental regulator of cardiac development and regeneration, functioning to secrete essential growth factors and to produce epicardium-derived cells that contribute coronary mural cells and cardiac fibroblasts. The molecular mechanisms controlling epicardial formation have not been fully elucidated. In this study, we report that the RNA-binding protein SRSF3 is highly expressed in the embryonic proepicardium and epicardial layer. Deletion of Srsf3 from the murine proepicardium led to proliferative arrest, preventing proper epicardial formation. Induction of Srsf3 deletion after the proepicardial stage resulted in impaired epicardial proliferation and epicardium-derived cell formation. Single-cell RNA sequencing showed that SRSF3-depleted epicardial cells were eliminated; however, the surviving non-recombined cells upregulated Srsf3, became hyperproliferative and, remarkably, compensated for the early deficit. This unexpected finding attests to the importance of SRSF3 in controlling epicardial proliferation, and highlights the significant confounding effect of mosaic recombination on embryonic phenotyping. Mapping the SRSF3-RNA interaction network by endogenous irCLIP identified binding to major cell cycle regulators, including Ccnd1 and Map4k4, mediating both splicing and non-splicing roles. This research defines SRSF3 as an important regulator of epicardial formation and function.

Indexed as

Cell ProliferationPericardiumRNA SplicingSerine-Arginine Splicing FactorsAnimalsCyclin D1Gene Expression Regulation, DevelopmentalMiceRNA-Binding ProteinsCcnd1 protein, mouseCyclin D1RNA-Binding ProteinsSerine-Arginine Splicing FactorsSrsf3 protein, mouseEpicardiumInducible Cre recombinaseMosaic recombinationMouseProliferationSRSF3Tamoxifen

Identifiers

PMID41601313
PMCPMC13006530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.